News | Point-of-Care Ultrasound (POCUS) | October 16, 2025

Next evolution of Venue family features new digital tools to assist users in conducting exams with increased confidence and less complexity.

Photo: GE Healthcare


Oct. 15, 2025 — GE HealthCare has announced the latest advancement in its Venue family of point-of-care ultrasound (POCUS) systems, now enhanced with new artificial intelligence (AI)-enabled and digital tools designed to boost confidence and efficiency. New tools include Nerveblox, an AI-enabled feature that automatically labels anatomical landmarks in the ultrasound image, designed to help clinicians feel confident during the peripheral nerve block procedure and streamline the workflow.

Additional AI-enabled and digital tools aim to simplify bladder volume measurements, and support complex and advanced ultrasound exams in the point of care setting. These enhancements extend across the entire Venue portfolio, including Venue, Venue Go, Venue Fit and Venue Sprint. 

“Our ultrasound portfolio is continuously evolving to meet the dynamic needs of clinicians, and we’re committed to driving innovation that makes our solutions more versatile, adaptable and impactful,” said Karley Yoder, CEO of Comprehensive Care Ultrasound, Advanced Visualization Solutions at GE HealthCare. “With the latest Venue family systems, we’re proud to add new tools that enhance the use of POCUS in anesthesiology and pain management and enhance other tools and features that empower clinicians across all experience levels to deliver confident care anytime, anywhere.” 

POCUS is designed to transform care by allowing clinicians to make faster, more confident decisions using real-time imaging across a wide variety of care scenarios.  These ultrasound systems can be found in emergency, critical care, anesthesia and other clinical settings to guide diagnosis and procedures. In anesthesia, ultrasound is increasingly used to enhance visualization during procedures such as regional blocks and vascular access, intended to support precision and patient safety.  

To support this evolving application, Venue family ultrasound systems incorporate AI-enabled features to assist clinicians in performing safe procedures. To advance anesthesiology care, a new AI feature, Nerveblox, is available to automatically label key anatomical landmarks in the ultrasound image and has demonstrated a 97% anatomical structure identification accuracy.i With this technology, Venue ultrasound systems support a broad range of nerve blocks, assisting clinicians with conducting 12 of the most common types of regional anesthesia procedures. This solution aims to help clinicians feel confident during the procedure, streamline workflow and reduce procedure time.  

“Nerveblox immediately impressed me. It provides a clear, colorful image of the target area in less than a second for multiple nerve blocks,” said Dr. Olivier Choquet, Montpellier University Hospital, France. “I tested it with different approaches, and its performance should be excellent in helping the practitioner locate key anatomical structures before inserting the needle. This feature is truly impressive.”    

The latest Venue family ultrasound systems introduce advanced imaging modes and new AI-enabled tools that can simplify the scanning process, enhance speed and accuracy during assessments and decision making, including: 

  • Contrast Enhanced Ultrasound, an advanced imaging mode that enables dynamic bedside evaluation of abdominal injuries and lesions.  

  • Auto Bladder Volume, which simplifies urinary bladder volume measurement from two views, reducing exam clicks. This feature is also now available on the wireless Vscan Air™ CL probe that can also connect to the Venue family systems. 

  • For cardiac assessments, Automated Function Imaging provides objective analysis of myocardial strain across heart chambers. In addition to the existing Caption Guidance™ AI-enabled software, which provides turn-by-turn, on-screen guidance to help expert and non-expert users capture diagnostic-quality cardiac ultrasound images. 

The latest Venue family ultrasound systems are U.S. FDA cleared and CE Marked for the European Union and are available in other markets where regulatory approval has been granted.

For more information, visit: www.gehealthcare.com/products/ultrasound/venue-family/venue-family-innovation


Related Content

News | Radiology Business

March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...

Time March 13, 2026
arrow
News | Enterprise Imaging

Mar. 9, 2026 — GE HealthCare recently announced that View, the viewer within the Genesis Radiology Workspace, has ...

Time March 12, 2026
arrow
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | FDA

Mar. 9, 2026 — GE HealthCare's View, the powerful viewer within the Genesis Radiology Workspace, has received 510(k) ...

Time March 09, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiology Business

March 5, 2026 — Cassling is now accepting applications for the 2026 Imaging for Impact Award, a national recognition ...

Time March 05, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
Subscribe Now